Published in Subst Abuse Rehabil on July 17, 2012
Safety and efficacy of acamprosate for the treatment of alcohol dependence. Subst Abuse (2013) 0.86
Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders. Lancet (2009) 16.12
Health economic assessment: a methodological primer. Int J Environ Res Public Health (2009) 1.52
Acamprosate in alcohol dependence: how does it work? Addiction (1995) 1.41
Double-blind randomized multicentre trial of acamprosate in maintaining abstinence from alcohol. Alcohol Alcohol (1995) 1.21
Comparison of acamprosate and placebo in long-term treatment of alcohol dependence. Lancet (1996) 1.20
Relapse prevention by acamprosate. Results from a placebo-controlled study on alcohol dependence. Arch Gen Psychiatry (1996) 1.18
An open multicentric study evaluating 4-hydroxybutyric acid sodium salt in the medium-term treatment of 179 alcohol dependent subjects. GHB Study Group. Alcohol Alcohol (1996) 1.02
The long-term cost-effectiveness of improving alcohol abstinence with adjuvant acamprosate. Alcohol Alcohol (2000) 0.99
A cost-effectiveness analysis of different therapies in patients with chronic hepatitis B in Italy. Clinicoecon Outcomes Res (2011) 0.94
The cost effectiveness of acamprosate in the treatment of alcoholism in Germany. Economic evaluation of the Prevention of Relapse with Acamprosate in the Management of Alcoholism (PRAMA) Study. Pharmacoeconomics (1998) 0.87
Impact of alcoholism treatment on total health care costs: a six-year study. Adv Alcohol Subst Abuse (1986) 0.86
Alcoholism. The cost of illness in the Federal Republic of Germany. Pharmacoeconomics (1996) 0.86
Methodological assessment of economic evaluations of alcohol treatment: what is missing? Alcohol Alcohol (2009) 0.85
Economic evaluation of Campral (Acamprosate) compared to placebo in maintaining abstinence in alcohol-dependent patients. Eur Addict Res (2000) 0.81
Two methods of estimating health costs linked to alcoholism in France (with a note on social costs). Alcohol Alcohol (2001) 0.81
Acamprosate as an aid in the treatment of alcoholism. Alcohol Alcohol (1995) 0.79
Discounting of health benefits in the pharmacoeconomic analysis of drug therapies: an issue for debate? Pharmacoeconomics (1992) 0.78